185 related articles for article (PubMed ID: 37024334)
21. Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis.
Tosi U; Maayan O; An A; Lavieri MET; Guadix SW; DeRosa AP; Christos PJ; Pannullo S; Stieg PE; Brandmaier A; Knisely JPS; Ramakrishna R
J Neurooncol; 2022 Jan; 156(2):431-441. PubMed ID: 35040021
[TBL] [Abstract][Full Text] [Related]
22. A non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report.
Kambe A; Kamitani H; Watanabe T; Oka A; Inagaki H; Ishii T; Ueki K
Surg Neurol; 2005 Jan; 63(1):62-4; discussion 64-5. PubMed ID: 15639530
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic criteria for schwannomatosis.
MacCollin M; Chiocca EA; Evans DG; Friedman JM; Horvitz R; Jaramillo D; Lev M; Mautner VF; Niimura M; Plotkin SR; Sang CN; Stemmer-Rachamimov A; Roach ES
Neurology; 2005 Jun; 64(11):1838-45. PubMed ID: 15955931
[TBL] [Abstract][Full Text] [Related]
24. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.
Gehlhausen JR; Park SJ; Hickox AE; Shew M; Staser K; Rhodes SD; Menon K; Lajiness JD; Mwanthi M; Yang X; Yuan J; Territo P; Hutchins G; Nalepa G; Yang FC; Conway SJ; Heinz MG; Stemmer-Rachamimov A; Yates CW; Wade Clapp D
Hum Mol Genet; 2015 Jan; 24(1):1-8. PubMed ID: 25113746
[TBL] [Abstract][Full Text] [Related]
25. Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas.
Jiramongkolchai P; Schwartz MS; Friedman RA
Otolaryngol Clin North Am; 2023 Jun; 56(3):533-541. PubMed ID: 36964092
[TBL] [Abstract][Full Text] [Related]
26. [Neurofibromatosis type 2 in the otorhinolaryngological practice].
Subbotina MV; Berseneva AV
Vestn Otorinolaringol; 2024; 89(1):37-41. PubMed ID: 38506024
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide association analysis identifies a susceptibility locus for sporadic vestibular schwannoma at 9p21.
Sadler KV; Bowes J; Rowlands CF; Perez-Becerril C; van der Meer CM; King AT; Rutherford SA; Pathmanaban ON; Hammerbeck-Ward C; Lloyd SKW; Freeman SR; Williams R; Hannan CJ; Lewis D; Eyre S; Evans DG; Smith MJ
Brain; 2023 Jul; 146(7):2861-2868. PubMed ID: 36546557
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.
Kehrer-Sawatzki H; Kluwe L; Friedrich RE; Summerer A; Schäfer E; Wahlländer U; Matthies C; Gugel I; Farschtschi S; Hagel C; Cooper DN; Mautner VF
Hum Genet; 2018 Jul; 137(6-7):543-552. PubMed ID: 30006736
[TBL] [Abstract][Full Text] [Related]
29. Multiple cutaneous plexiform schwannomas. Report of a case and review of the literature with particular reference to the association with types 1 and 2 neurofibromatosis and schwannomatosis.
Reith JD; Goldblum JR
Arch Pathol Lab Med; 1996 Apr; 120(4):399-401. PubMed ID: 8619756
[TBL] [Abstract][Full Text] [Related]
30. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
31. Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.
Dirks MS; Butman JA; Kim HJ; Wu T; Morgan K; Tran AP; Lonser RR; Asthagiri AR
J Neurosurg; 2012 Jul; 117(1):109-17. PubMed ID: 22503123
[TBL] [Abstract][Full Text] [Related]
32. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
[TBL] [Abstract][Full Text] [Related]
33. New classification and approaches to the treatment of schwannomatosis.
Makashova ES; Zolotova SV; Absalyamova OV; Galkin MV; Petrokovskaya AV; Kozlov AV; Golanov AV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(5):104-109. PubMed ID: 37830475
[TBL] [Abstract][Full Text] [Related]
34. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.
Samii M; Matthies C; Tatagiba M
Neurosurgery; 1997 Apr; 40(4):696-705; discussion 705-6. PubMed ID: 9092842
[TBL] [Abstract][Full Text] [Related]
35. Translabyrinthine resection of neurofibromatosis type 2 associated vestibular and facial schwannomas, repair of facial nerve, and placement of auditory brainstem implant.
Schwartz MS; Lekovic GP; Brackmann DE; Voelker CC
Neurosurg Focus; 2014 Jan; 36(1 Suppl):1. PubMed ID: 24380525
[TBL] [Abstract][Full Text] [Related]
36. Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.
Smith MJ; Kulkarni A; Rustad C; Bowers NL; Wallace AJ; Holder SE; Heiberg A; Ramsden RT; Evans DG
Am J Med Genet A; 2012 Jan; 158A(1):215-9. PubMed ID: 22105938
[TBL] [Abstract][Full Text] [Related]
37. Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.
Plotkin SR; Allen J; Dhall G; Campian JL; Clapp DW; Fisher MJ; Jain RK; Tonsgard J; Ullrich NJ; Thomas C; Edwards LJ; Korf B; Packer R; Karajannis MA; Blakeley JO
Neuro Oncol; 2023 Aug; 25(8):1498-1506. PubMed ID: 37010875
[TBL] [Abstract][Full Text] [Related]
38. [Familial schwannomatosis, a new entity distinct from neurofibromatosis type 1 and 2].
Reinders JW; Koehler PJ
Ned Tijdschr Geneeskd; 2007 Aug; 151(34):1891-5. PubMed ID: 17902564
[TBL] [Abstract][Full Text] [Related]
39. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
Welling DB
Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
[TBL] [Abstract][Full Text] [Related]
40. A Critical Overview of Targeted Therapies for Vestibular Schwannoma.
Tamura R; Toda M
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
